Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19

By I. Paranjpe, Valentin Fuster, A. Lala, Adam J Russak, Benjamin S. Glicksberg, M. Levin, A. Charney, J. Narula, Z. Fayad, E. Bagiella and 2 more. Journal of the American College of Cardiology, 2020

875 citations recorded by the source corpus.

The novel coronavirus disease-2019 (COVID-19) has affected nearly every country worldwide. Reports note increased thromboembolic events among hospitalized patients ([1][1],[2][2]), and there are anecdotal observations of improved outcomes with systemic anticoagulation (AC); however, the specific

Subfields: Infectious Diseases, Neurology, Oncology

View Paper: https://www.semanticscholar.org/paper/ca84620c49e89a599e15bfc5e6637b827e74ccb7